Zenith Health Care Ltd (ZENITHHE) — shareholding pattern, promoter holding, financials and share price
About Zenith Health Care Ltd (ZENITHHE)
Zenith Health Care Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as ZENITHHE and on the BSE under scrip code 530665. Its ISIN is INE812B01026.
Incorporated in 1993, Zenith Health care Ltd is engaged in manufacturing and trading of pharma products [1]
Zenith Healthcare Limited is a comprehensive healthcare provider specializing in manufacturing various pharmaceutical forms such as tablets, capsules, ointments, and injectable liquids.
Strategically located in Gujarat, a major pharmaceutical hub, the company boasts significant manufacturing capabilities with ISO 9001:2008 and WHO-cGMP certifications.
Listed peers in Pharmaceuticals: Mono Pharmacare Ltd, Desh Rakshak Aushdhalaya Ltd, Dipna Pharmachem Ltd, Starsource Multitrade Ltd, Ortin Global Ltd, Saroja Pharma Industries India Ltd.
Valuation & Returns
10 Jul 2026At ₹3.1 a share on 10 Jul 2026, Zenith Health Care Ltd (ZENITHHE) was valued at a price-to-earnings ratio of -150.45x against an industry P/E of 36.41x and a price-to-book of 2.25x on a book value of ₹1.38 per share as of Mar 2025. Solomo computes return on capital employed of 0.27% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -150.45x
- Industry P/E
- 36.41x
- P/B
- 2.25x
- Book value / share
- ₹1.38
- ROCE
- 0.27%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 2.66%
- 52-week range
- ₹2.23 – ₹4.99
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Zenith Health Care Ltd (ZENITHHE) reported revenue of ₹10.52 crore and net profit of ₹0.01 crore. That compares with revenue of ₹11.33 crore and net profit of ₹0.07 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹2.62 crore and net profit ₹-0.34 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 22.36 | 13.13 | 14.47 | 11.33 | 10.52 |
| Net profit (₹ cr) | 0.31 | 0.08 | 0.2 | 0.07 | 0.01 |
| EPS (₹) | 0.06 | 0.01 | 0.04 | 0.01 | 0 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 13.44% | -1.11% | -20.28% | -21.70% |
| Profit growth | - | -34.73% | -40.03% | -65.00% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 28.74% of Zenith Health Care Ltd (ZENITHHE) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0.39%. Market capitalisation was ₹17 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2001.
Largest disclosed public shareholders in Jun 2026: SHARPLINE TRADING CO. PVT. LTD. 3.29%, HARSH JHAVERI 2.19%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 28.74% | - | - | 0.39% | 71.26% |
| Mar 2026 | 28.74% | - | - | 0.39% | 71.26% |
| Dec 2025 | 28.74% | - | - | 0.39% | 71.26% |
| Sep 2025 | 28.74% | - | - | 0.39% | 71.26% |
| Jun 2025 | 28.74% | - | - | 0.39% | 71.26% |
| Mar 2025 | 28.74% | - | - | 0.39% | 71.26% |
| Dec 2024 | 28.74% | - | - | 0.39% | 71.26% |
| Sep 2024 | 28.74% | - | - | 0.39% | 71.26% |